Literature DB >> 6467116

Is cimetidine being prescribed indiscriminately? An analytic survey of patients who present with symptoms of peptic ulcer disease.

T J Elmslie, W W Rosser, S J Sollars, M C Champion, R S Roberts.   

Abstract

An analytic survey was done to determine the influence of previously documented peptic ulcer disease (PUD) on the frequency of prescribing cimetidine to patients who present at a family medicine centre with symptoms of PUD. It was found that of 293 patients who presented with such symptoms over 1 year cimetidine was prescribed to 57 (19%). From the 236 patients who did not receive cimetidine 57 patients were selected at random for comparison. Information on these two groups of patients was obtained by chart review. The patients who received cimetidine were found to be significantly more likely (p less than 0.001) to have previously documented PUD than those who did not receive cimetidine. In patients in whom subsequent confirmation of PUD was not obtained, either because the results of investigations were negative or because the investigations were not ordered, cimetidine was prescribed to 63% of those who had previously documented PUD, compared with only 6% of those who did not. Of the patients who were investigated 73% of those with previously documented PUD had positive results, compared with 8% of those without previously documented PUD. The positive results were obtained by endoscopic examination in 88% of the patients with previously documented PUD, whereas upper gastrointestinal tract roentgenography was the definitive test in 73% of the patients without previously documented PUD. These findings suggest that previously documented PUD influences both the frequency of prescribing cimetidine and the investigations that are carried out.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467116      PMCID: PMC1483477     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  7 in total

1.  Bias in analytic research.

Authors:  D L Sackett
Journal:  J Chronic Dis       Date:  1979

Review 2.  Current therapy in peptic ulcer.

Authors:  I N Marks
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

3.  How physicians use cimetidine: a survey of hospitalized patients and published cases.

Authors:  R R Schade; R M Donaldson
Journal:  N Engl J Med       Date:  1981-05-21       Impact factor: 91.245

4.  A survey of cimetidine prescribing.

Authors:  A E Cocco; D V Cocco
Journal:  N Engl J Med       Date:  1981-05-21       Impact factor: 91.245

5.  Nonindicated use of cimetidine.

Authors:  R P Lafrate; W L Russel
Journal:  Am J Hosp Pharm       Date:  1980-11

6.  Use of cimetidine in hospital patients.

Authors:  K W Hall; M Behun; J Irvine-Meek; N Otten
Journal:  Can Med Assoc J       Date:  1981-06-15       Impact factor: 8.262

7.  Cimetidine postmarket outpatient surveillance program. Interim report on phase I.

Authors:  L M Gifford; M E Aeugle; R M Myerson; P J Tannenbaum
Journal:  JAMA       Date:  1980-04-18       Impact factor: 56.272

  7 in total
  5 in total

Review 1.  An approach to dyspepsia in the ambulatory care setting: evaluation based on risk stratification.

Authors:  S C Zell; M Budhraja
Journal:  J Gen Intern Med       Date:  1989 Mar-Apr       Impact factor: 5.128

2.  Prescribing by canadian general practitioners: review of the english language literature.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

3.  Computerization of family practice.

Authors:  T Elmslie; W W Rosser
Journal:  CMAJ       Date:  1986-02-01       Impact factor: 8.262

4.  Medical education reduces inappropriate use of cimetidine in a teaching hospital.

Authors:  D C Gardiner; M C Champion; D Sweet; K Kozakowski; A Wielgosz
Journal:  CMAJ       Date:  1985-09-01       Impact factor: 8.262

5.  Approach to dyspepsia.

Authors:  T Koppert; T J Elmslie
Journal:  Can Fam Physician       Date:  1988-03       Impact factor: 3.275

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.